Charterhouse Capital Partners
Charterhouse-backed Cooper bolts on Diepharmex
Geneva-headquartered Diepharmex manufactures products for hygiene and ear care such as ear sprays
Charterhouse exits cheese specialist Nuova Castelli to trade
Sale ends a five-year holding period for Charterhouse, which owned an 80% stake in the company
Charterhouse agrees £668m Tarsus take-private
Deal values shares in the Irish media and events business at 17x its average EBITDA in 2017 and 2018
Charterhouse's Siaci Saint Honore bolts on Driesassur
SSH, backed by Charterhouse since 2018, bolts on jewellery insurance specialist Driesassur
Charterhouse reaps 2.4x on sale of Comexposium
Comexposium is sold to Crédit Agricole Assurances after three years under Charterhouse's ownership
Charterhouse considers secondaries deal for ninth fund
Vehicle launched in March 2008 with a €6bn target but held a final close on €4bn in 2009
Charterhouse acquires Funecap
Management equally reinvests in funeral service Funecap, which posts an EBITDA of around €40m
Charterhouse eyes France's Funecap
ICG provided Funecap with €350m in unitranche debt at the end of last year
Ardian, Edmond de Rothschild exit Siaci Saint Honore
Charterhouse takes over, acquiring a minority stake in the insurance brokerage business
Charterhouse's Optima bolts on Giuso Guido
Following Giuso Guido's acquisition, Optima expects to reach a turnover of €190m in 2018
Charterhouse's Cooper-Vemedia buys 12 Sanofi brands for €158m
Deal is the second major bolt-on acquisition for the group since the GP acquired it in 2015
Charterhouse acquires 3i-backed SLR
Deal brings to an end a 10-year holding period for 3i, during which the company doubled its EBITDA
Charterhouse-backed Comexposium in €355m refinancing
Comexposium secures a term loan B facility from ING, Natixis, Deutsche Bank and Societe Generale
Inflexion, CVC funds trading above NAV, says secondaries marketplace
Inflexion's 2010-vintage buyout fund is trading at nearly a quarter above NAV, according to Palico
Charterhouse takes majority stake in Serb
Deal will be the first ever buyout for the Belgian speciality pharmaceuticals group
Oakley adds Charterhouse partner Mornington to string of hires
New partner will focus on deal origination, deal execution and portfolio management
Charterhouse X holds final close on €2.3bn
Fund's previous generation Charterhouse IX has reportedly returned in excess of 3x money with five exits
Charterhouse buys ice-cream ingredients maker Optima
GP acquired the business through its 2015-vintage 10th vehicle, Charterhouse X
Charterhouse-backed Comexposium in €394m refinancing
New debt package for the French events management business sees leverage hitting 4x EBITDA
Charterhouse buys Sagemcom from Carlyle
Tertiary buyout sees the Carlyle Group selling the business after five years at the helm
Deal in focus: IK sells Vemedia to Charterhouse Capital
Vendor's international buy-and-build strategy helped transform the Belgian pharmaceutical company into a pan-European force
CVC appoints Charterhouse's Eberle as investment director
New recruit joins the firm's London-based TMT team after four years at Charterhouse
CVC, Charterhouse, Permira fully exit Saga
The private equity consortium sold their remaining 32% stake in the company
CVC acquires Doc Generici from Charterhouse
Charterhouse's ninth fund scores a 2.7x money multiple with a 40% IRR following the sale